Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Phase 2 Study of Ex-vivo Perfusion and Ventilation of Lungs to Assess Transplant Suitability

This study has been terminated.
(Funding exhausted.)
XVIVO Perfusion
Information provided by (Responsible Party):
Tom Egan, MD,MsC, University of North Carolina, Chapel Hill Identifier:
First received: November 12, 2010
Last updated: July 8, 2016
Last verified: July 2016
No Study Results Posted on for this Study
  Study Status: This study has been terminated.
  Study Completion Date: June 2013
  Primary Completion Date: December 2012 (Final data collection date for primary outcome measure)